Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia
口服 AKT 抑制剂 MK-2206 治疗急性髓性白血病的临床前和早期临床评估
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-13-1978
Marina Y Konopleva, Roland B Walter, Stefan H Faderl, Elias J Jabbour, Zhihong Zeng, Gautam Borthakur, Xuelin Huang, Tapan M Kadia, Peter P Ruvolo, Jennie B Feliu, Hongbo Lu, Lakiesha Debose, Jan A Burger, Michael Andreeff, Wenbin Liu, Keith A Baggerly, Steven M Kornblau, L Austin Doyle, Elihu H Est